Market Research Logo

Global Human Vaccine Market 2018-2022

Global Human Vaccine Market 2018-2022

About Human Vaccine

Vaccines are biological preparations used to confer active acquired immunity against a host-causing disease. Vaccines have been impacting the global health scenario by reducing disease incidence, mortality rates, and life expectancy.

Technavio’s analysts forecast the Global Human Vaccine Market to grow at a CAGR of 7.73% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the human vaccine market. To calculate the market size, the report considers the revenue generated from the retail sales of human vaccines across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, human vaccines market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
Market driver
  • Growing investments in vaccine segment
  • For a full, detailed list, view our report
Market challenge
  • Rising pricing pressure
  • For a full, detailed list, view our report
Market trend
  • Varied demand for vaccines in high-income and developing countries
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


PRESS RELEASE

Technavio Announces the Publication of its Research Report - Global Human Vaccine Market 2018-2022

Technavio recognizes the following companies as the key players in the global human vaccine market: GlaxoSmithKline, Merck, Pfizer, and Sanofi.

Commenting on the report, an analyst from Technavio’s team said: “One trend affecting this market is the varied demand for vaccines in high-income and developing countries. The demand for novel vaccines is high in developing economies as they receive financial support.”

According to the report, one driver influencing this market is the increase in investments in vaccine segment. High investments by vaccine manufacturers are necessary to develop a wide variety of vaccines, reduce product and process complexity, and maintain aggressive timelines for vaccine development and life cycle management.

Further, the report states that one challenge affecting this market is the rising pricing pressure. Leading companies have been under pressure from medical associations to lower the price of vaccines so that governments can procure them for public immunization programs.

Companies Mentioned

GlaxoSmithKline
Merck
Pfizer
Sanofi

  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Parent market
      • Table Global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Pipeline analysis
    • Table Pipeline analysis
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global - Market size and forecast 2017-2022 ($ bn)
      • Table Global - Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by ROA
    • Segmentation by ROA
      • Table ROA - Market share 2017-2022 (%)
    • Comparison by ROA
      • Table Comparison by ROA
    • Oral - Market size and forecast 2017-2022
      • Table Oral - Market size and forecast 2017-2022 ($ bn)
      • Table Oral - Year-over-year growth 2018-2022 (%)
    • Intramuscular - Market size and forecast 2017- 2022
      • Table Intramuscular - Market size and forecast 2017-2022 ($ bn)
      • Table Intramuscular - Year-over-year growth 2018-2022 (%)
    • Intradermal - Market size and forecast 2017- 2022
      • Table Intradermal - Market size and forecast 2017-2022 ($ bn)
      • Table Intradermal - Year-over-year growth 2018-2022 (%)
    • Subcutaneous - Market size and forecast 2017- 2022
      • Table Subcutaneous - Market size and forecast 2017-2022 ($ bn)
      • Table Subcutaneous - Year-over-year growth 2018-2022 (%)
    • Intranasal - Market size and forecast 2017-2022
      • Table Intranasal - Market size and forecast 2017-2022 ($ bn)
      • Table Intranasal - Year-over-year growth 2018-2022 (%)
    • Market opportunity by ROA
      • Table Market opportunity by ROA
  • Market segmentation by vaccine type
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global - Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas - Market size and forecast 2017-2022
      • Table Americas - Market size and forecast 2017-2022 ($ bn)
      • Table Americas - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in Americas
    • EMEA - Market size and forecast 2017-2022
      • Table EMEA - Market size and forecast 2017-2022 ($ bn)
      • Table EMEA - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in EMEA
    • APAC - Market size and forecast 2017-2022
      • Table APAC - Market size and forecast 2017-2022 ($ bn)
      • Table APAC - Year-over-year growth 2018-2022 (%)
      • Table Top 3 countries in APAC
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Varied demand for vaccines in high-income and developing countries
    • Increase in strategic alliances and M&A
      • Table Major alliances and M&A in vaccine segment
    • Public-private partnership models and technology transfer to local players
      • Table Vaccines under development by small players
    • Innovative partnerships improving global vaccine access
    • Emergence of new technologies for delivery of vaccines
    • Differential pricing to accelerate uptake in lowincome countries
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • GlaxoSmithKline
      • Table GlaxoSmithKline - Overview
      • Table GlaxoSmithKline - Business segments
      • Table GlaxoSmithKline - Organizational developments
      • Table GlaxoSmithKline - Geographic focus
      • Table GlaxoSmithKline - Segment focus
      • Table GlaxoSmithKline - Key offerings
    • Merck
      • Table Merck - Overview
      • Table Merck - Business segments
      • Table Merck - Organizational developments
      • Table Merck - Geographic focus
      • Table Merck - Segment focus
      • Table Merck - Key offering
    • Pfizer
      • Table Pfizer - Overview
      • Table Pfizer - Business segments
      • Table Pfizer - Organizational developments
      • Table Pfizer - Geographic focus
      • Table Pfizer - Segment focus
      • Table Pfizer - Key offering
    • Sanofi
      • Table Sanofi - Overview
      • Table Sanofi - Business segments
      • Table Sanofi - Organizational developments
      • Table Sanofi- Geographic focus
      • Table Sanofi - Segment focus
      • Table Sanofi - Key offering
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report